UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 92 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | -100.0% | 76 | -99.9% | 0.00% | – |
Q2 2022 | $49,000 | – | 86,888 | +47379.8% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 183 | -99.5% | 0.00% | – |
Q4 2021 | $53,000 | -84.9% | 36,057 | -69.1% | 0.00% | – |
Q3 2021 | $350,000 | -9.1% | 116,677 | +40.5% | 0.00% | – |
Q2 2021 | $385,000 | -44.3% | 83,056 | -27.9% | 0.00% | – |
Q1 2021 | $691,000 | +12.9% | 115,147 | -1.3% | 0.00% | – |
Q4 2020 | $612,000 | +247.7% | 116,713 | +130.3% | 0.00% | – |
Q3 2020 | $176,000 | -54.4% | 50,668 | +13.8% | 0.00% | – |
Q2 2020 | $386,000 | +185.9% | 44,507 | +90.2% | 0.00% | – |
Q1 2020 | $135,000 | -20.1% | 23,406 | -0.4% | 0.00% | – |
Q4 2019 | $169,000 | +3.0% | 23,501 | -12.5% | 0.00% | – |
Q3 2019 | $164,000 | -24.4% | 26,851 | +17.7% | 0.00% | – |
Q2 2019 | $217,000 | +14.8% | 22,822 | -1.9% | 0.00% | – |
Q1 2019 | $189,000 | -36.4% | 23,262 | +27.7% | 0.00% | – |
Q4 2018 | $297,000 | +1250.0% | 18,222 | +1273.2% | 0.00% | – |
Q3 2018 | $22,000 | +69.2% | 1,327 | +47.6% | 0.00% | – |
Q2 2018 | $13,000 | – | 899 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund V Management, LLC | 491,751 | $275,000 | 2.22% |
GSA CAPITAL PARTNERS LLP | 639,937 | $361,000 | 0.05% |
PURA VIDA INVESTMENTS, LLC | 359,089 | $202,000 | 0.01% |
Caption Management, LLC | 725,000 | $409,000 | 0.01% |
Forefront Analytics, LLC | 20,377 | $11,000 | 0.01% |
Johnson Midwest Financial, LLC | 6,100 | $3,000 | 0.00% |
Virtu Financial LLC | 62,640 | $35,000 | 0.00% |
Caption Management, LLC | 225,000 | $127,000 | 0.00% |
SeaCrest Wealth Management, LLC | 25,000 | $14,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 191,450 | $108,000 | 0.00% |